| __timestamp | Novavax, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19928000 | 49315000 |
| Thursday, January 1, 2015 | 30842000 | 75043000 |
| Friday, January 1, 2016 | 46527000 | 83749000 |
| Sunday, January 1, 2017 | 34451000 | 122682000 |
| Monday, January 1, 2018 | 34409000 | 207761000 |
| Tuesday, January 1, 2019 | 34417000 | 284812000 |
| Wednesday, January 1, 2020 | 145290000 | 317875000 |
| Friday, January 1, 2021 | 298358000 | 282660000 |
| Saturday, January 1, 2022 | 488691000 | 451421000 |
| Sunday, January 1, 2023 | 468946000 | 481871000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Sarepta Therapeutics, Inc. and Novavax, Inc. from 2014 to 2023. Over this period, Sarepta's SG&A expenses grew by approximately 878%, while Novavax saw an astonishing increase of around 2,254%. Notably, in 2022, Novavax's expenses peaked at nearly 490 million, surpassing Sarepta's 451 million. This trend highlights the aggressive expansion and operational scaling of these companies, especially during the COVID-19 pandemic when Novavax was at the forefront of vaccine development. As these companies continue to innovate, understanding their financial strategies offers valuable insights into their market positioning and future growth potential.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Sarepta Therapeutics, Inc.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Sarepta Therapeutics, Inc.
Selling, General, and Administrative Costs: Bio-Techne Corporation vs Sarepta Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Blueprint Medicines Corporation
Sarepta Therapeutics, Inc. vs Amicus Therapeutics, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Ascendis Pharma A/S vs Novavax, Inc.
ADMA Biologics, Inc. vs Novavax, Inc.: SG&A Expense Trends
Geron Corporation or Novavax, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Iovance Biotherapeutics, Inc. vs Novavax, Inc.
Selling, General, and Administrative Costs: BioCryst Pharmaceuticals, Inc. vs Novavax, Inc.
Selling, General, and Administrative Costs: Evotec SE vs Novavax, Inc.